A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma.

Saved in:
Bibliographic Details
Title: A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma.
Authors: Burge, M. E.1, Smith, D.2, Topham, C.3, Jackson, D. P.1, Anthoney, D. A.1, Halstead, F.1, Seymour, M. T.1 Matt.Seymour@leedsth.nhs.uk
Source: British Journal of Cancer. 5/8/2006, Vol. 94 Issue 9, p1281-1286. 6p. 6 Charts.
Database: Academic Search Ultimate
Description
ISSN:00070920
DOI:10.1038/sj.bjc.6603084